Literature DB >> 12622923

Genetic polymorphisms of CYP2D6 in Chinese mainland.

Ling Ji1, Shixiu Pan, Jianmin Wu, Jacqueline Marti-Jaun, Martin Hersberger.   

Abstract

OBJECTIVE: To observe the significant differences in the frequencies of the cytochrome P450 2D6 (CYP2D6) alleles in Chinese popoulations.
METHODS: Tetra-primer polymerase chain reaction (PCR), allele specific amplification (ASA) PCR and multiplex long PCR were developed to detect the CYP2D6 alleles * 2, * 3, * 4, * 5, * 6, * 8, * 10 and * 14 in 223 subjects from Chinese mainland.
RESULTS: The CYP2D6 * 5 allele was the most frequent poor metabolizer (PM) allele in Chinese (7.2%), followed by CYP2D6 * 14 (2.0%) which was only detected in orientals. There was only 0.2% CYP2D6 * 4, and no CYP2D6 * 3, * 6 and * 8 were detected. In contrast to the Caucasians, the most frequent allele in Chinese was the * 10 allele with a frequency of 51.6%.
CONCLUSION: The frequencies of PM alleles, CYP2D6 * 5 and CYP2D6 * 14, were higher; but the frequency of CYP2D6 * 10 was lower in mainland Chinese population than that in other orientals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12622923

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.

Authors:  Ya-Huei Liou; Chien-Ting Lin; Ying-Jye Wu; Lawrence Shih-Hsin Wu
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

Review 2.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Three cases of severe hepatic impairment caused by erlotinib.

Authors:  Yi-Sheng Huang; She-Juan An; Zhi-Hong Chen; Yi-Long Wu
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

4.  Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.

Authors:  Kai-fa Tang; Yi-li Zhao; Shang-shu Ding; Qi-fei Wu; Xing-yang Wang; Jia-qi Shi; Fa Sun; Jun-ping Xing
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

5.  Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.

Authors:  A Gaedigk; A Bhathena; L Ndjountché; R E Pearce; S M Abdel-Rahman; S W Alander; L DiAnne Bradford; P K Rogan; J Steven Leeder
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

6.  Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.

Authors:  Hong Dong; Shu-Jun Lu; Rui Zhang; Dong-Dong Liu; Yan-Zhuo Zhang; Chun-Yu Song
Journal:  Eur J Clin Pharmacol       Date:  2015-05-08       Impact factor: 2.953

Review 7.  Copy number variants in pharmacogenetic genes.

Authors:  Yijing He; Janelle M Hoskins; Howard L McLeod
Journal:  Trends Mol Med       Date:  2011-03-08       Impact factor: 11.951

8.  Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia.

Authors:  Yanfeng Wang; Li Zhou; Catherine Dutreix; Elisabeth Leroy; Qi Yin; Venkat Sethuraman; Gilles-Jacques Riviere; Ophelia Q P Yin; Horst Schran; Zhi-Xiang Shen
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

9.  Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele.

Authors:  Yi M Cui; Choo H Teng; Alan X Pan; Eunice Yuen; Kwee P Yeo; Ying Zhou; Xia Zhao; Amanda J Long; Mark E Bangs; Stephen D Wise
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

10.  Genetic polymorphisms analysis of CYP2D6 in the Uygur population.

Authors:  Xue He; Na He; Lisong Ren; Yongri Ouyang; Ning Zhang; Yini Ma; Dongya Yuan; Longli Kang; Tianbo Jin
Journal:  BMC Genomics       Date:  2016-05-26       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.